Try it free

Samsung Biologics

Sustainability Report and Carbon Intensity Rankings

50 - 200 Employees
Website
Linkedin

Is Samsung Biologics doing their part?

Their DitchCarbon score is 40

Samsung Biologics has a DitchCarbon Score of 40 out of 100, indicating moderate performance in sustainability practices. This score reflects the company’s current carbon intensity level, suggesting there is significant room for improvement in reducing emissions. A higher score would demonstrate a stronger commitment to lowering carbon intensity and enhancing overall environmental sustainability.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Samsung Biologics is part of the research and development sector, which has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Unknown

High

Very high

Samsung Biologics, based in South Korea, operates in a region with a specific carbon intensity rating. The sustainability of the company’s operations is influenced by South Korea’s national efforts to manage its carbon footprint.
11.36%

...this company is doing 11.36% worse in emissions than the industry average.

Samsung BioLogics, founded in 2011 and headquartered in Incheon, South Korea, operates in the biopharmaceutical industry as a leading Contract Manufacturing Organization (CMO). The company specializes in the research and development, manufacturing, and global distribution of biopharmaceutical products, adhering to stringent cGMP regulations. With a commitment to quality and customer-oriented services, Samsung BioLogics is poised for global expansion, aiming to make a significant impact on healthcare worldwide.
Compare Samsung Biologics with other companies in the same industry –>

emission intelligence's platform recommendations for Samsung Biologics

Samsung Biologics should consider the implementation of green procurement policies to source low-carbon energy and services, which could potentially reduce their emissions by 0.3%.
Full recommendation sample, Adobe ->

Bad news, Samsung Biologics hasn't committed to SBTi goals yet

Samsung Biologics has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining clear, science-based emissions reduction targets to align with global efforts to mitigate climate change.
Not participating

The Ultimate Guide to Building Sustainability Into Procurement​

1. Reputation and Brand Image

2. Corporate Social Responsibility

3. Becoming a Customer of Choice

4. Stakeholder Engagement

5. Risk Management

Download PDF

Case study — How Compleat's clients use our carbon data

Making Compleat’s customers climate heroes. Download the 19-page case study PDF.
Download

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Claim this profile ->

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Learn about our methodology ->

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.
Full list of companies
Contact us

Quicklinks

About
Privacy Policy
License agreement
Billing
Login

Resources

Blog
API documentation
Industry sustainability reports
Find a company's emissions data
Free to use SBTi API

Get in touch

Email: enquiries@ditchcarbon.com
Tel: +44 203 475 7875
Office: Ditch Carbon Ltd
167-169 Great Portland Street
London W1W 5PF
Linkedin
DitchCarbon Limited © 2024